Evaluating complex health interventions: a critical analysis of the 'outcomes' concept by Paterson, Charlotte et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Complementary and 
Alternative Medicine
Open Access Debate
Evaluating complex health interventions: a critical analysis of the 
'outcomes' concept
Charlotte Paterson†1, Charlotte Baarts†2, Laila Launsø†3,4 and Marja 
J Verhoef*†5
Address: 1Institute of Health Services Research, Peninsula Medical School, University of Exeter, Exeter, UK, 2Department of Sociology, University 
of Copenhagen, Øster Farimagsgade 5, POB 2099, DK-1014 Copenhagen K, Denmark, 3The National Research Center in Complementary and 
Alternative Medicine (NAFKAM), The Medical Faculty, University of Tromsø, 9037 Tromsø, Norway, 4The Danish Multiple Sclerosis Society, 
Mosedalvej 15, 2500 Valby, Denmark and 5Department of Community Health Sciences, University of Calgary, 3330 Hospital Drive NW, Calgary, 
T2N 4N1, Canada
Email: Charlotte Paterson - charlotte.paterson@pms.ac.uk; Charlotte Baarts - cba@soc.ku.dk; Laila Launsø - Launsoe@post7.tele.dk; Marja 
J Verhoef* - mverhoef@ucalgary.ca
* Corresponding author    †Equal contributors
Abstract
Background: The extent to which a health care intervention causes or facilitates health-related
change is a key question in research. The need to quantify such change has led to the development
of an increasing number of change indicators, to measure what have come to be known as
'outcomes'. In the context of medical research into the efficacy or effectiveness of an intervention
the term 'outcomes' has often been interpreted to mean single endpoints with a linear cause and
effect link to an external intervention.
Discussion: In this paper we present a critical analysis of the nature and interpretation of the
'outcomes' concept and of the assumptions that underpin it. Drawing on our own work and that
of others, we analyse the problems that arise when the concept is applied to complex interventions
and discuss the use of other models, such as programme theory, as a basis for alternative
conceptualisations for indicators of change.
Our analysis demonstrates that the interpretation of 'outcomes' that may be appropriate for clinical
trials of pharmaceutical products, is problematic when used in evaluations of complex interventions
in areas such as complementary medicine, palliative care, rehabilitation, and health promotion. The
'outcomes' concept may impose inappropriate patterns of thought and meaning. We present
alternative models, such as those based on programme theory, which conceptualise health-related
change as resulting from the interaction between intervention, process and context over time. In
this framework both the intervention and the patient are defined as causal factors, because the
result of the treatment is dependent on the resources of the patient – such as the body's ability to
heal itself – and the impact of the patient's situation.
Summary: Evaluations based on a model such as programme theory will encompass a wide range
of health-related changes that include aspects of process, such as new meanings and understanding,
as well as longer term changes in health, wellbeing and health-related competences and behaviours.
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Background
The extent to which a health care intervention causes or
facilitates health-related change is a key question in
research into complementary and alternative medicine. It
is a question posed by patients, providers and policy mak-
ers and is researched at different levels using a range of
research designs and qualitative and quantitative meth-
ods. The need to quantify such change has led to the
development of an increasing number of change indica-
tors, which include 'objective' and 'subjective' parameters.
These indicators have come to be known as 'outcomes'
and measuring these outcomes, by means of validated
instruments and questionnaires, is now an important
field of academic activity that generates a plethora of
health-related outcome measures and associated method-
ological debate. Figure 1 illustrates the exponential
increase in academic activity related to this contemporary
conceptualisation of 'outcomes' over the last twenty years.
In relation to complementary and alternative therapies,
this activity includes both generic and problem-specific
measures and their use in randomised controlled trials
(RCTs) and descriptive outcome studies [1-3]. However,
in the context of medical research into the efficacy or
effectiveness of an intervention, there has been limited
critical analysis of the nature and interpretation of the
'outcomes' concept or of the assumptions that underpin
it. As outcomes assessment is essential in determining
whether and how health-related change occurs, such an
analysis is urgently needed.
Biomedicine has been highly successful in assessing the
outcomes of pharmaceutical interventions on the basis of
changes in pathology, symptoms, and other biological
indicators. This assessment is usually focused on a single
organ system or disease process. However, the application
of these outcome measures to interventions in areas such
as complementary medicine, palliative care, rehabilita-
tion, mental health and health promotion is proving to be
problematic. In these situations, people often experience
a wide range of changes that extend beyond the common
biomedical, psychological or quality of life outcomes and
they may emphasize the process of healing as well as the
impact of contextual factors [4-13]. The interrelated
nature of treatment processes and outcomes and the vari-
able and often long timeframe of change are becoming
recurrent themes in research papers in these areas [14-18].
In addition, the alternative therapeutic and healing theo-
ries that underpin many of these interventions have
important implications for the outcomes that are aimed
for and experienced [19-22]. While there has been consid-
erable debate about overall research design for complex
interventions, especially the use of randomised controlled
trials (RCTs) [20,23-29] it is not our intention to focus on
this debate here. In this paper we focus on the meaning of
the concepts 'outcomes' and 'outcome measurement',
which are core concerns for both observational and exper-
imental research and programme evaluations.
In the context of medical research into the efficacy or
effectiveness of an intervention, where the RCT remains
top of the hierarchy of evidence, the term 'outcomes' is
generally interpreted to mean single endpoints with a lin-
ear cause and effect link to an external intervention.
Whilst this may be appropriate in the discourse in which
the term originated, clinical trials of pharmaceutical prod-
ucts, the continuing use of the term in other discourses
may impose inappropriate patterns of thought and mean-
ing. Take, for example, the use of 'outcomes' to describe
changes in health, wellbeing and health-related behav-
iours in the context of someone with long-term illness
engaging in a complex intervention – such as someone
with arthritis and depression engaging in group exercise
such as Tai Chi. In this situation, this interpretation of
'outcomes' may narrow the assessment of change to a sin-
gle quantifiable indicator and divert attention away from
the important contextual factors, feedback loops, the
users' experiences and learning processes and individual-
ised long-term outcomes. Calls for the use of a wider
range of patient-centred outcome measures, especially in
areas such as rehabilitation, mental health [18], and com-
plementary medicine [30] have had only a limited effect
on outcome measurement in clinical trials. This interpre-
tation of the concept of 'outcomes' tends to have the effect
of 'freezing' experiences at one point in time, although
experiences change over time, and it does not illuminate
the potential and limits of the health-related changes. Our
own research into patients' experiences of complex inter-
ventions leads us to believe that a critical analysis of the
concept of outcomes will assist in identifying and better
Number of 'hits' on Medline (on Ovid) search for "outcome  assessment (health care)" or "outcome assessment".mp Figure 1
Number of 'hits' on Medline (on Ovid) search for 
"outcome assessment (health care)" or "outcome 
assessment".mp, Limited by year.
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understanding the challenges that we all face, in whatever
discipline, in measuring outcomes appropriately.
This paper will trace the evolution of the concept of 'out-
comes' from its beginnings in clinical trials of pharmaceu-
ticals to its current use in evaluations of complex
interventions. In so doing we will examine the assump-
tions that underpin the use of the concept in pharmaceu-
tical trials and how they play out when it is used in
different circumstances. Drawing on our own work and
that of others, we will highlight the problems that arise
when the concept is applied to complex interventions and
use the example of programme theory to illustrate how
researchers can develop alternative conceptualisations for
indicators of change. Finally we will return to the out-
comes of clinical trials of pharmaceuticals and reflect on
the current problems in putting evidence from these trials
into practice and how a new understanding of outcomes
can help to overcome them.
Discussion
A. Critical Analysis of the Concept of 'outcomes'
Outcomes in a disease-focused pharmaceutical trial
Starting with the development of the concept of 'outcome
measurement' in pharmaceutical trials, let us consider a
placebo controlled trial of a drug which aims to counter-
act, at a molecular level, the inflammatory response in
rheumatoid arthritis (RA). The drug is known experimen-
tally to have its maximal effect after 8 weeks and so the
primary outcome chosen is an objective measure of the
degree and number of swollen joints at 8 weeks. The
researchers, following best practice, include as secondary
outcome measures the core set from the OMERACT (Out-
come Measures in Rheumatoid Arthritis Clinical Trials)
conference – often held up as an example of excellence in
outcome measurement- plus some patient-centred subjec-
tive measures as recommended by more recent OMERACT
workshops (See Table 1 for details of OMERACT). Within
this context we can see that the concept of outcomes, as an
'endpoint', reflects the theoretical assumptions of the
intervention being evaluated and the research question
being addressed and that it has been applied using a
patient-centred approach. Establishing the efficacy of the
drug in this way is, of course, only part of establishing its
utility – in terms of effectiveness and safety in the real
world – and we will return to the problems associated
with translating the findings of trials into everyday prac-
tice in section C. First, however, we will analyse the under-
lying assumptions that underpin the concept of
'outcomes' in such a trial and explore how these assump-
tions affect the measurement of change in evaluations of
complex interventions, especially within the field of com-
plementary and alternative medicine.
Assumptions that underpin the concept of 'outcomes'
One result of the burgeoning field of 'outcomes' is that
there is a tendency for 'outcomes' to be conceptualised as
having some reality of their own, without a particular con-
text and purpose. However, terms and concepts such as
'outcomes' are inevitably linked to underlying assump-
tions and meanings which may not be evident to users of
the term. To continue our example of people with RA, we
know that in addition to, or instead of, taking pharmaceu-
tical treatments many such patients will also be using
complementary therapies [31]. Consequently, there has
been a call for evidence of the efficacy of complementary
therapies that has largely been answered by designing tri-
als which measure the same 'best practice' primary 'out-
comes' as used in pharmaceutical trials. It is in this context
that the underlying assumptions about 'outcomes'
become important. Uncovering and critically analysing
these assumptions enables us to free the concept of out-
come, in the more general sense of 'consequence of', from
the particular concept of 'outcomes' as used in efficacy or
effectiveness research, dominated as it is by the RCT
research paradigm. Through a process of multi-discipli-
Table 1: OMERACT – best practice in disease-focused pharmaceutical trials
The first OMERACT conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials [1] achieved agreement on a core set of outcomes 
measures to be used as a minimum in every clinical trial of rheumatoid arthritis (RA). These consist of acute phase reactants, disability, pain, patient 
global assessment, physician global assessment, swollen joint count, tender joint count, and radiographic studies of joints in any trial of 1 year or 
longer. Recently OMERACT has begun exploring the patient's perspectives of outcomes in RA [2,3]. Patients identified as important not just 
physical outcomes such as pain and disability, but also sleep disturbance, fatigue, "a general feeling of wellness" and "a return to normality".
Hughes et al [4] have investigated the extent to which this 'best practice' in outcome measurement for RA trials reflects the outcomes experienced 
after a complex intervention. Their work on the outcomes aimed for and experienced by a range of acupuncture practitioners treating people with 
RA indicates that even with the addition of the subjective patient-centred measures, the OMERACT set of outcome measures would miss many of 
the treatment effects that were identified, effects that were diverse, unpredictable and long-term.
1. Tugwell P, Boers M: OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol 
1993, 20: 528–530.
2. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmen M et al.: Outcomes from the Patient Perspective Workshop at OMERACT 
6. J Rheumatol 2003, 30: 868–872.
3. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M et al.: Rheumatology outcomes: the patient's perspective. J Rheumatol 2003, 30: 
880–883.
4. Hughes JG, Goldbart J, Fairhurst E, Knowles K: Exploring acupuncturists' perceptions of treating patients with rheumatoid arthritis. 
Complement Ther Med 2007, 15: 101–108.BMC Complementary and Alternative Medicine 2009, 9:18 http://www.biomedcentral.com/1472-6882/9/18
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nary group discussions during a residential workshop (see
acknowledgements) we have identified the following
assumptions as underpinning the concept of 'outcomes'
as it is usually used within the context of clinical drug tri-
als:
1. An intervention is directed at preventing, moderating or
curing one disease process.
2. The change in the disease process will be predictable and
similar in its form for every patient (although variable in its
degree).
3. There is a linear cause and effect relationship between
the intervention and the change in the disease process and
the intervention is perceived as a separate entity not includ-
ing the patient.
4. Context effects – such as the effects of the therapeutic
relationship, the material and emotional aspects of the
patients' life-worlds, changes in health beliefs and behav-
iours – are separate from the effect of the intervention
under study.
5. Ideally, objective change indicators for the disease proc-
ess are specified as the primary outcome. Subjective meas-
ures such as pain scores are only used as primary outcomes
if there is no alternative, and in these situations high prior-
ity is given to developing new objective measures, by means
of new technologies such as MRI scans and biochemical
assays.
6. Subjective changes in health are a consequence of the
change in the disease process, and are therefore measured
as secondary outcomes. They do not usually contribute to
the statistical outcome of a trial or evaluation.
7. The timeframe of the maximal response to treatment can
be predicted by pharmacological and experimental evi-
dence, so that the primary outcome is measured as a single
endpoint. Longer term follow-up is an optional add-on to
assess whether change is sustained.
8. It is often assumed that 'outcomes' relate primarily to
changes that are being measured in randomised controlled
trials.
In the following section we will review the validity of each
of these assumptions for evaluating complex interven-
tions for people with long-term conditions. This will be
followed by a discussion of how to move forward to an
alternative conceptualisation of measuring change in
these situations. First, however, we briefly address our use
of the term 'complex intervention'.
Complex interventions
The term 'complex interventions' has been defined and
used in a number of ways. The Medical Research Council's
framework for the evaluation of complex interventions
defines a complex intervention as 'built up from a number
of components, which may act both independently and inter-
dependently' and suggests that early phase research is nec-
essary to define the 'active ingredients' [24,32]. Others
have suggested that such interventions are better termed
'complicated' and that complexity, based on complexity
theory, is represented by 'recursive causality (with reinforc-
ing loops), disproportionate relationships (where at critical lev-
els, a small change can make a big difference – a 'tipping
point') and emergent outcomes' [33] (pp29). A slightly dif-
ferent formulation is to describe a complex systems
approach, which is promoted as making us 'consider the
wider ramifications of intervening and to be aware of the inter-
action that occurs between components of the intervention as
well as between the intervention and the context in which it is
implemented' [34]. In terms of health care, complex inter-
ventions are sometimes simply defined as non-pharmaceu-
tical or as involving a high level of patient participation. In
this paper we use the term 'complex intervention' to
encompass complicated and complex health care inter-
ventions which are non-pharmaceutical and participative,
such as the example of Tai Chi given above. Such interven-
tions are the norm in many areas of health care such as
complementary and alternative therapies, health promo-
tion and rehabilitation.
The applicability of the above assumptions to evaluating complex 
interventions
Drawing on our own qualitative and quantitative work in
the areas of patients' experiences of complex interven-
tions, particularly complementary, alternative and inte-
grative care, we will discuss to what extent each of the
assumptions listed above holds true in the context of com-
plex interventions.
1. An intervention is directed at preventing, moderating or
curing one disease process.
AND
2. The change in the disease process will be predictable and
similar in its form for every patient (although variable in its
degree).
Many complex interventions are focused on the whole
individual person rather than on one disease process and
in some cases this whole person approach is underpinned
by an alternative therapeutic theory base, such as Chinese
medicine theory or psychoanalytic theory. Although such
interventions may take one symptom, or disease process,
as a point of departure, the treatment process evolves toBMC Complementary and Alternative Medicine 2009, 9:18 http://www.biomedcentral.com/1472-6882/9/18
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include the whole person and their history. In these situa-
tions there is no rational basis for a disease-focused out-
come. Because the intervention is directed at each person
as a unique individual, the nature of the changes, their
timeframe and their social consequences will be unpre-
dictable and individualised [13]. In addition these first
two assumptions indicate that the patient is perceived as
passive and accepting, whereas many complex interven-
tions, especially in relation to people with long-term con-
ditions, necessitate viewing the patient as an active
participant in their own treatment strategy. We will return
to this issue of people as active agents later, in section C,
when we consider how to translate trial evidence into
practice.
3. There is a linear cause and effect relationship between
the intervention and the change in the disease process and
the intervention is perceived as a separate entity not includ-
ing the patient.
AND
4. Context effects – such as the effects of the therapeutic rela-
tionship, the material and emotional aspects of the patients'
life-worlds, changes in health beliefs and behaviours – are sep-
arate from the effect of the intervention under study.
Many users, health care providers and researchers, are
socialized into thinking that the intervention, understood
as an autonomous technical intervention, is the determin-
ing factor in producing the particular outcomes. Whilst
this may be largely true for the acute effects of powerful
drugs, a linear cause and effect relationship is not consist-
ent with complex interventions that are directed at the
person as a whole being. In his classic text on holism [35],
Smuts describes how the linear concept of cause and effect
that is observed within mechanical structures undergoes a
radical transformation when observed in the case of a
holistic structure, such as an organism:
'When an external cause acts on a whole, the resultant effect is
not merely traceable to the cause, but has become transformed
in the process. The whole seems to absorb and metabolise the
external stimulus and to assimilate it into its own activity; and
the resultant response is no longer the passive effect of the stim-
ulus or cause, but appears as the activity of the whole'
[35](pp126).
More recent empirical research demonstrates that the
effects of complex interventions are perceived, by both
patients and therapists, to be related not only to the inter-
vention itself but also to their communication and rela-
tionship, changes in patients' understanding of the
meaning and cause of their symptoms, and the patients'
own efforts and activities – factors that are sometimes
termed 'context effects' [36]. Most importantly, these
effects are not seen as separate from the specific interven-
tion, but rather as the interplay between the intervention,
the communication, the user's understanding of symp-
toms and the user's own efforts (actions) that develop in
an ongoing process [13,16,30,37-40]. This process is also
related to the patient's life situation, including the influ-
ence of social, cultural, economical and political factors
[15,41]. In fact, the specific intervention may sometimes
have less effect on the outcomes than the contextual and
communicative aspects [7].
The experiences summarized in Table 2 illustrate this
complexity and indicate that assumptions 3 and 4 are not
reflected in these patients' experiences. The report given
by Sussi in Table 2 illustrates how the reflexology treat-
ment focused on the wider context of body-mind and acti-
vated Sussi's awareness and preventive behavior, thus
combining the treatment prevention and health promo-
tion. Self-regulating activities were set in motion, repre-
senting complex causal processes that led to positive
processes and health-related change. Through the social
interaction between Sussi and her therapist, the present-
ing symptom, headache, was transformed from a specific
entity to a broader contextualized phenomenon.
Consequently for complex interventions it is necessary to
replace decontextualised, linear cause and effect models
with more complex conceptual models that identify the
assumptions that underlie the intervention as well as its
process and context
Table 2: Data from a qualitative interview conducted in a 
research project on headache and reflexology treatment. []
"When the headaches started to disappear I told myself to calm down, 
because I expected them to return quickly – I actually did. But I just kept 
getting better....it was like being reborn....I had been spending a lot of time 
feeling unwell – time I should have spent with my family. It was really like 
being back in business. I actually think that it was my own mental process 
that made a change". In addition, the reflexologist has helped Sussi to get 
rid of her heartburn and bloated stomach – a problem that had previously 
required a lot of medicine – and has taught Sussi to press a key point in her 
ear if she got a bloated stomach. Sussi believes that the reflexology has also 
reduced her colds and sore throats, which had been frequent problems 
since childhood, and she no longer needed to use penicillin.
After the fifth treatment Sussi started to cut down a lot on her coffee 
intake: she says that her body now tells her what is good and what is bad 
for her. Whereas Sussi started with the feeling that the headaches were 
something she wanted to rip out, she now understands her headaches in 
another way and has a holistic understanding of her body.
1. Brendstrup E, Launsø L. Headache and reflexological 
treatment. Copenhagen: The Council Concerning Alternative 
Treatment, National Board of Health; 1997.
The client was diagnosed by a medical specialist as having migraine at 
the start of the treatment project [1]BMC Complementary and Alternative Medicine 2009, 9:18 http://www.biomedcentral.com/1472-6882/9/18
Page 6 of 11
(page number not for citation purposes)
5. Ideally, objective change indicators for the disease process are
specified as the primary outcome. Subjective measures such as
pain scores are only used as primary outcomes if there is no
alternative, and in these situations high priority is given to
developing new objective measures, by means of new technolo-
gies such as MRI scans and biochemical assays.
AND
6. Subjective changes in health are a consequence of the
change in the disease process, and are therefore measured
as secondary outcomes. They do not usually contribute to
the statistical outcome of a trial or evaluation.
Patients seeking out non-pharmaceutical interventions
such as complementary and alternative medicine often
want help with multiple biomedical diagnoses. This
makes the search for a single disease-focused primary out-
come inappropriate. As illustrated by the data in Table 3,
the outcomes for such patients may be very complex and
they may be focused on other outcomes than mere health.
The hierarchy of outcomes that results from prioritising
objective outcomes over subjective ones, a hierarchy that
is being promoted by the use of new scientific technolo-
gies such as MRI scans and biochemical assays, severely
compromises the validity of outcome measurement for
complex interventions. Measuring subjective outcomes
but then excluding them from the main findings of the
evaluation, is yet another example of the dominance of
the medical gaze over the life-world of the patient [42,43].
We suggest that whilst it is helpful to differentiate between
outcomes independent of the patient's awareness (blood
tests, scanning etc.) and experience dependent on the
patient's awareness (pain, gaining control etc) [8] this
range of outcomes should be part of a complex model and
understanding that illustrates that treatment effects are
not purely, or sometimes not at all, the result of changes
in disease processes.
7. The timeframe of the maximal response to treatment can
be predicted by pharmacological and experimental evi-
dence, so that the primary outcome is measured at a single
endpoint. Longer term follow-up is an optional add-on to
assess whether change is sustained.
This assumption, based like the others on the model of
pharmaceutical research, is a poor fit for complex inter-
ventions, the effects of which are experienced by patients
as part of longer chain of more or less interdependent
effects – what we conceptualise as 'process' or 'change'.
Effects may disappear, reappear and other changes may be
experienced much later on [15,44,45]. In addition non-
pharmaceutical interventions are themselves complex and
relational and capable of adapting to individual patients
changing wants and needs over time [13]. In this situation
the use of 'outcomes' as an endpoint, results in such out-
comes representing mere expressions of experiences con-
ceptualised in a particular way at particular time in a
particular place: when the patient had to fill in the ques-
tionnaire.
Table 3: Main categories of 'outcomes' of complex interventions [1]
1. Treatment results connected to body sensation
• Physical effects like physical symptoms diminishing or disappearing (pain, infections, constipation, tension, fatigue, etc.), strengthening of the 
immune system, etc.
• Mental effects like removal of blockages, getting more energy, better sleep, increased quality of life, better general condition, feeling attended to/
safeguarded.
• 'Side gains' like diminishing or disappearance of other physical symptoms than the ones that the user told the treatment provider about.
• Short term responses to the treatment like a change in body odor, increased amount of faeces, change in the odour of the urine, head ache, old 
symptoms re-appearing.
• Long term responses -
2. Changes in awareness, understanding, insight
• Increased bodily consiousness and bodily awareness like being able to listen to and interpreting body signals.
• Changes in the knowledge and understanding of, and insight into ones disease/symptoms, including putting into words other ways to understand 
disease than the biomedical understanding.
• Some sort of transformation, understood as an individual, seeking, self integrating, and never ending health-related change process.
• Putting into words spiritual aspects and tools for working with spiritual aspects of life.
• Greater awareness of one self in different social settings.
3. Changes in actions and development of new competences in the role as one's own 'disease manager' – especially important for people with chronic disease
• Develop a larger room of action and find ones own resources (drive).
• Develop tools to handle life situations, including social activities.
• Develop knowledge and tools to prevent symptoms and to promote health.
1. Launsø L: Therapists' effect assumptions and users' own effort-when people with chronic diseases consult conventional and 
alternative therapists [in Danish with english abstract]. Tidsskrift for Forskning i Sygdom & Samfund [Journal of Research in Disease & Society] 
2008, 9: 97–112.BMC Complementary and Alternative Medicine 2009, 9:18 http://www.biomedcentral.com/1472-6882/9/18
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The importance of timeframe is accentuated in the case of
people living with long-term illness. Research findings
indicate that people go through different stages or phases
of experience as they find their own individual way of
coping and adapting to changing health and disability
[46,47]. These 'illness careers' follow individualised paths
which depend on personal characteristics, patterns of ill-
ness progression, whether there is experience of the illness
amongst family and friends, and the wider cultural and
material context of life. The effects of any interventions are
intertwined with the effects of the associated biographical
disruption [48] and attempts to rebuild personal and
social identities [49-51]. Realistic aims may reflect a desire
for safety, stability or a slowing of deterioration [52,53].
8. It is often assumed that 'outcomes' relate primarily to
changes that are being measured in randomised controlled
trials.
The position of randomised controlled trials at the apex of
the evidence-based medicine approach to evaluation
should not detract from the many other situations in
which outcome measurement is important. These include
early stage research that investigates the relationships
between process, context and outcome over time; descrip-
tive outcome studies; mixed method service evaluations;
and practitioners seeking to improve their practice
through case studies and audit. Not all these research
methods require the measurement of 'before and after'
primary quantitative outcomes and the reduction of
change in health, wellbeing and health-related behaviours
to single endpoints is unlikely to answer the questions
posed. Being clear about the purpose of outcomes assess-
ment, is a necessary pre-requisite for identifying indicators
of change and how to measure, or observe, them.
B. Addressing the Challenges of Measuring Change in 
Relation to Complex Interventions
In the previous section, we have demonstrated why and
how the current concept of 'outcomes' and the way that it
is commonly employed in clinical drug trials, is problem-
atic in evaluating complex interventions, especially the
use of complementary and alternative medicine by people
with long-term health problems. We have used some
examples from primary research to illustrate the chal-
lenges we face and how the choice of outcome affects the
scope and level of knowledge that can be understood and
described. The challenges that we have identified include
the need to encompass and measure those changes that
are intangible, rather than concrete; those that are individ-
ualised, rather than normative; those that are embedded
in the context of the intervention, rather than clearly issu-
ing from it; and those that are related to the discourses of
contemporary society.
Using complex conceptual models
There are a number of different research frameworks, the-
oretical approaches and models that encompass different
conceptualisations of outcomes. Frameworks include the
recently updated MRC framework for evaluating complex
interventions, which acknowledges the need to analyse
multiple outcomes over longer time periods and to relate
them to process [32] and the integrated quantitative and
qualitative approach to developing and evaluating com-
plex interventions exemplified by Bradley et al [54]. Other
health service evaluators have used action research [55]
and systems theory [41] approaches. In the field of public
health the RE-AIM Model conceptualizes the public
health impact of an intervention as a function of five fac-
tors: reach, efficacy, adoption, implementation and main-
tenance [56] and a classic model used in quality assurance
in health care links outcomes to both structure and proc-
ess [57].
In the field of complementary medicine research, a
number of papers have developed conceptual models
relating to outcomes from primary or secondary research
[9,40,41] but these have generally not been based on a
more generalisable theoretical framework. One exception
to this has been the application of programme theory to
evaluating complementary therapies and we will describe
this work in more detail as an example of an alternative
conceptualisation of outcomes. Further work in this area
will allow for better understanding of the role of pro-
gramme theory and other theoretical frameworks in eval-
uating a variety of complementary therapies in different
populations and contexts.
Programme theory applied to complementary therapies
Programme theory (intervention theory, logic modelling)
has been developed to research and evaluate social poli-
cies, programmes and initiatives and it conceptualises
outcome as linked to both mechanism and context [58-
60]. It provides a tool to understand and explain what
works for whom, in what circumstances, in what respects,
and how. Used as a basis for constructing conceptual
models of complex health care interventions, programme
theory ensures that such models include not only the
intervention and the outcomes but also explicitly represents
the components and dynamic of the process and the social
and cultural contexts. The IPCOE framework depicted in
Figure 2 is an example of such a model that has been
developed in relation to team-based interventions involv-
ing conventional, complementary and alternative thera-
pies for people with long-term health problems [8]. In
this model 'outcomes' includes both 'outcomes independ-
ent of the patient's awareness' and 'experiences dependent
on the patients awareness'.BMC Complementary and Alternative Medicine 2009, 9:18 http://www.biomedcentral.com/1472-6882/9/18
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The  intervention  is described in terms of its theoretical
basis, as well as its components and dynamics, and this
may include lay theories and assumptions as well as pro-
fessional and therapy based theories and the wider social
theories that come into play. In developing and applying
the IPCOE framework, the first task has been to explore
and make explicit the intervention theory (theories),
including the practitioners' underlying assumptions
about how an intervention is intended to work and what
impacts this is expected to have. The processes  in the
IPCOE framework involve internal processes such as bio-
psycho-mental-neuro-immunological processes, body
sensation, body awareness and understanding; change in
behaviour, testing out new actions and competencies and
these processes can be perceived as a series of interrelated
actions, changes, reactions or functions that happen over
time as an individual moves from one state of health to
another. Attending to process focuses on not only whether
change occurred, but how the change occurred. Context is
the set of circumstances within which the intervention
and the processes take place, which may include the
patient-provider relationship, treatment setting, other
treatments in use, the patient's living situation and eco-
nomic, social, cultural and political factors. The model
highlights the interrelationships and feedback loops that
occur over time such that the process is grounded in the
social cultural and political contexts, unfolding over time
and facilitating or inhibiting the outcomes. Research find-
ings also indicate that the user's learning is an essential
ingredient in their treatment trajectory [16,39,40,61].
The use of programme theory, using tools based on the
IPCOE framework, is proving valuable in an investigation
of whether collaboration between conventional and alter-
native practitioners may optimize treatment results for
people who have multiple sclerosis [8]. In the first stage of
the project each therapist was asked to fill in the frame-
work for their respective treatment models outlining typi-
cal interventions, the assumed mechanisms, expected
outcomes, and relevant contextual factors that may influ-
ence the outcome positively or negatively. These were
then shared between practitioners and discussed at practi-
tioner-researcher seminars, a process that demonstrated
and made explicit the significant differences between con-
ventional and alternative practitioners and led to self-
reflection and improved understanding of how the team
could work together.
The 'outcomes' concept in programme theory
In a framework such as that depicted in Figure 2, it is clear
that there is not a linear cause-and -effect relationship
between intervention and outcome, but rather that
health-related change results from the interaction
between intervention, process and context over time. Thus
the interventions achieve their effects via the active input
of the individual internal processes and contexts [59]. In
this framework both the intervention and the patient are
defined as causal factors, because the result of the treat-
ment is dependent on the resources of the patient – such
as the body's ability to heal itself – and the impact of the
patient's situation. In addition, rather than depicting out-
comes as objective and subjective, the framework includes
both 'outcomes independent of the patient's awareness'
and 'experiences dependent on the patient's awareness'
and accords them equal significance. Using the concept of
experiences, as against subjective outcomes, highlights the
dynamic and relational aspect of this phenomenon and
its connection with learning. Learning and experience
interact, based on the treatment intervention, communi-
cation between practitioner and user, the user's efforts and
actions and the user's social contexts [16,39,40,61]. Such
experiences will include categories such as 'new holistic
understandings'[40], increased self-awareness [9], and
'learning new things' [62] found in other studies of com-
plementary medicine. Using such a model based on pro-
gramme theory results in a wide range of health-related
changes and a list of potential changes is provided in
Table 3. This list, and the inclusion of the category
'Changes in actions and the development of new competences
in the role as one's own 'disease manager' is based on research
with people with a variety of chronic health problems
who accessed complementary and alternative treatment
[16,63]. Similar categories of change have been identified
by other researchers into complementary and integrative
health care [9,13,30,44,45,64,65].
IPCOE: a frame of reference for researching health-related  change of complex interventions Figure 2
IPCOE: a frame of reference for researching health-
related change of complex interventions.
The IPCOE- conceptual frame
IPCOE:  Intervention, Processes, Contexts, Outcomes, Experiences
Intervention
Complex, 
complicated  
participative
Processes
Activating body internal processes;
Bio-psycho- mental- neuro-immunological processes; 
body sensation, body awareness and understanding;
Change in behaviour / new actions;
Development of competencies.
Contexts
Treatment setting; other treatments in use;
the patient’s living situation; disease history;
Social, cultural, economic & political factors
Outcomes 
independent
of the patient’s  awareness
Experiences 
dependent
on the patient’s awarenessBMC Complementary and Alternative Medicine 2009, 9:18 http://www.biomedcentral.com/1472-6882/9/18
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C: Applying the Benefits of Complex Conceptual Models 
to Implementing Trial Results
Although we have indicated that the assumptions under-
lying the measurement of 'outcomes' in clinical drug trials
are generally appropriate for evaluating pharmaceuticals,
there is a particular aspect of these research programmes
which would benefit from a greater awareness of the vari-
ous interpretations and alternative models of outcomes.
This aspect is the implementation of the findings of clini-
cal drug trials into routine practice – an aspect that is caus-
ing increasing concern within the evidence-based
medicine movement and in health service policy. For
example, research shows that despite all the new antihy-
pertensive drugs, the blood pressure of the majority of
hypertensive patients is inadequately controlled [66] and
that only about 50% of drugs that are prescribed are taken
correctly [67]. This suggests that, even for pharmaceutical
interventions, their use in the real world constitutes a
complex intervention in which the underlying assump-
tions, beliefs and everyday contexts of both patients and
providers play important and inter-related roles. Develop-
ing conceptual models of these complexities will help to
encourage awareness of different interpretations of 'out-
comes' that take into account a wider range of issues that
are affecting patient and provider behaviour. For example,
a synthesis of the qualitative studies of the lay experience
of medicine taking found that the main reason why peo-
ple do not take their medicines as prescribed is because of
a lay resistance to taking medicines [68]. The synthesis
depicts the complex nature of this resistance and the asso-
ciated behaviours as a diagrammatic 'model of medicine
taking' which can be used to improve concordance and
adherence.
Summary
This critical analysis of the concept and term 'outcomes',
as commonly used in clinical drug trial research, has
uncovered the underlying assumptions on which it has,
necessarily, been constructed. This analysis indicates that
in this context 'outcomes' are often conceptualised as dis-
ease-focused endpoints of a linear cause and effect inter-
vention, which are ideally measured in terms of a single
objective primary outcome at a fixed time-point. Context
effects, which include aspects of the process of the inter-
vention and the wider context of peoples' lives, are viewed
as separate entities which are best removed from the eval-
uation process by means of a randomised controlled trial
design. Our analysis indicates that whilst this concept of
outcome may be appropriate for measuring the short-
term efficacy of pharmaceutical interventions, it is inap-
propriate for most complex interventions. Even within
pharmaceutical based research, this concept of 'outcomes'
is insufficient for measuring the effectiveness of interven-
tions in the real world, or for understanding and interven-
ing in the implementation of clinical trial findings.
The use of complex conceptual models, such as those
based on programme theory, are a basis for understanding
the complexity of the experience of health-care interven-
tions within the wider social and cultural context of peo-
ples' lives. They are an alternative basis on which to
understand and evaluate the changes in health and well-
being associated with many complementary and alterna-
tive medicine interventions and to understand the role of
various factors in promoting positive changes. Our own
work with people with long-term conditions who use
complementary therapies illustrates that models built on
the findings of in-depth qualitative research provide a
basis on which to design evaluations and develop indica-
tors of change. These indicators of change need to include
aspects of process, such as new meanings and understand-
ing, as well as longer term changes in health, wellbeing
and health-related competences and behaviours. These
models lead to a different interpretation of 'outcomes'
which encompasses the interactions and learning that
constitutes the treatment experience over time, and views
the patient as an active agent who will interact with an
intervention in ways that produce individualised changes.
Current and future work in this field will improve our
ability to measure aspects of these complex changes with
quantitative instruments and questionnaires, and to com-
bine this with qualitative methods in mixed-method eval-
uations.
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